In conclusion, we have provided functional in vitro evidence that EP2/EP4 are potential therapeutical targets having a role in the regulation of MC degranulation that may prevent EIB in asthma by nullifying the hyperosmolar-induced degranulation of airway mast cells. This evidence concerns the gene PTGER4 and asthma.